Our results, taken in context with previous findings, suggest that the role CIRP plays in inflammation in cancer is context-dependent, explaining why CIRP increases pro-tumorigenic inflammation in colorectal and liver cancers [18,19] while decreasing pro-tumorigenic inflammation in breast cancer, as well as decreasing inflammation in wound healing [70]. This evidence concerns the gene CIRBP and breast cancer.